CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment.
CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment.
复制标题
CDKL5 缺乏症相关癫痫:当前和新兴治疗的回顾。
作者:
Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) is a developmental and epileptic encephalopathy with infantile-onset epilepsy. Most individuals with CDD develop refractory epilepsy with multiple seizure types. Management of seizures in CDD remains challenging for clinicians given the highly refractory nature of seizures and the limited number of disease-specific studies that offer a high level of evidence. Epileptic spasms are the most common seizure type in CDD and are more often refractory to standard first-line treatment compared to spasms of other etiologies. In other seizure types, effectiveness of anti-seizure medications is limited and wanes over time. Ketogenic diet and palliative surgical treatments both have mixed results in observational studies. When treating refractory seizures in CDD, we recommend carefully balancing seizure control and treatment related side effects to optimize each individual’s overall quality of life. There have been clinical trials for medications targeting epilepsy in CDD, and additional investigational small molecules, gene therapy, and other disease-modifying therapies are in development for CDD.
登录
查看更多内容
影响因子:
9.3
作者:
Galvani G;Mottolese N;Gennaccaro L;Loi M;Medici G;Tassinari M;Fuchs C;Ciani E;Trazzi S
通讯作者:
Trazzi S
影响因子:
9.9
作者:
Fehr, Stephanie;Wong, Kingsley;Leonard, Helen
通讯作者:
Leonard, Helen
影响因子:
4.7
作者:
Fuchs, Claudia;Gennaccaro, Laura;Ciani, Elisabetta
通讯作者:
Ciani, Elisabetta
影响因子:
14.5
作者:
Bahi-Buisson, Nadia;Nectoux, Juliette;Bienvenu, Thierry
通讯作者:
Bienvenu, Thierry
影响因子:
2.6
作者:
Dale, Tristan;Downs, Jenny;Leonard, Helen
通讯作者:
Leonard, Helen